111 related articles for article (PubMed ID: 15973180)
1. Low pretransplant bone-mineral density and rapid bone loss do not increase risk for avascular osteonecrosis after allogeneic hematopoietic stem cell transplantation.
Schulte CM; Beelen DW
Transplantation; 2005 Jun; 79(12):1748-55. PubMed ID: 15973180
[TBL] [Abstract][Full Text] [Related]
2. Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter.
Schulte CM; Beelen DW
Transplantation; 2004 Oct; 78(7):1055-63. PubMed ID: 15480174
[TBL] [Abstract][Full Text] [Related]
3. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review.
Tauchmanovà L; De Rosa G; Serio B; Fazioli F; Mainolfi C; Lombardi G; Colao A; Salvatore M; Rotoli B; Selleri C
Cancer; 2003 May; 97(10):2453-61. PubMed ID: 12733144
[TBL] [Abstract][Full Text] [Related]
4. Long-lasting bone damage detected by dual-energy x-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation.
Tauchmanovà L; Serio B; Del Puente A; Risitano AM; Esposito A; De Rosa G; Lombardi G; Colao A; Rotoli B; Selleri C
J Clin Endocrinol Metab; 2002 Nov; 87(11):5058-65. PubMed ID: 12414872
[TBL] [Abstract][Full Text] [Related]
5. Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study.
Gandhi MK; Lekamwasam S; Inman I; Kaptoge S; Sizer L; Love S; Bearcroft PW; Milligan TP; Price CP; Marcus RE; Compston JE
Br J Haematol; 2003 May; 121(3):462-8. PubMed ID: 12716369
[TBL] [Abstract][Full Text] [Related]
6. Bone loss following hematopoietic stem cell transplantation: a long-term follow-up.
Schulte CM; Beelen DW
Blood; 2004 May; 103(10):3635-43. PubMed ID: 14630805
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP
J Bone Miner Res; 1999 Mar; 14(3):342-50. PubMed ID: 10027899
[TBL] [Abstract][Full Text] [Related]
8. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
9. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study.
Stern JM; Sullivan KM; Ott SM; Seidel K; Fink JC; Longton G; Sherrard DJ
Biol Blood Marrow Transplant; 2001; 7(5):257-64. PubMed ID: 11400947
[TBL] [Abstract][Full Text] [Related]
10. Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation.
Law AD; Bhella S; Pasic I; Lam W; Michelis FV; Gerbitz A; Viswabandya A; Kumar R; Lipton JH; Mattsson J; Kim DDH
Ann Hematol; 2021 May; 100(5):1311-1319. PubMed ID: 33710366
[TBL] [Abstract][Full Text] [Related]
11. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
12. Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation.
Yao S; Smiley SL; West K; Lamonica D; Battiwalla M; McCarthy PL; Hahn T
Biol Blood Marrow Transplant; 2010 Aug; 16(8):1130-7. PubMed ID: 20188201
[TBL] [Abstract][Full Text] [Related]
13. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
Beksac M; Celebi H; Sargín D; Yalcin A; Topcuoglu P; Kalayoglu-Besisik S; Beyan C; Arslan O; Ozcan M; Gurman G; Ilhan O; Akan H
Bone Marrow Transplant; 2003 May; 31(10):897-904. PubMed ID: 12748666
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors.
Anandi P; Jain NA; Tian X; Wu CO; Pophali PA; Koklanaris E; Ito S; Savani BN; Barrett J; Battiwalla M
Bone Marrow Transplant; 2016 Aug; 51(8):1101-6. PubMed ID: 27042843
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy.
Stamatović D; Balint B; Tukić L; Elez M; Tarabar O; Todorović M; Todorić-Zivanović B; Ostojić G; Tatomirović Z; Marjanović S; Malesević M
Vojnosanit Pregl; 2012 Jan; 69(1):37-42. PubMed ID: 22397295
[TBL] [Abstract][Full Text] [Related]
16. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
DeAngelo DJ; Hochberg EP; Alyea EP; Longtine J; Lee S; Galinsky I; Parekkedon B; Ritz J; Antin JH; Stone RM; Soiffer RJ
Clin Cancer Res; 2004 Aug; 10(15):5065-71. PubMed ID: 15297408
[TBL] [Abstract][Full Text] [Related]
17. A potential graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: results from the French Bone Marrow Transplantation Society.
Espérou H; Boiron JM; Cayuela JM; Blanchet O; Kuentz M; Jouet JP; Milpied N; Cahn JY; Faucher C; Bourhis JH; Michallet M; Tanguy ML; Vernant JP; Gabert J; Bordigoni P; Ifrah N; Baruchel A; Dombret H;
Bone Marrow Transplant; 2003 May; 31(10):909-18. PubMed ID: 12748668
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for reduced areal bone mineral density in young adults with stem cell transplantation in childhood.
Taskinen M; Kananen K; Välimäki M; Löyttyniemi E; Hovi L; Saarinen-Pihkala U; Lipsanen-Nyman M
Pediatr Transplant; 2006 Feb; 10(1):90-7. PubMed ID: 16499594
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.
Xu LP; Xu ZL; Zhang XH; Chen H; Chen YH; Han W; Chen Y; Wang FR; Wang JZ; Wang Y; Yan CH; Mo XD; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1080-1086. PubMed ID: 26995693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
